Curis announces $8.5 million private placement of common stock and warrants
Curis entered into a Securities Purchase Agreement on October 16, 2026 for the sale of 16,666,680 shares of common stock (or pre-funded warrants) and common warrants to purchase up to 16,666,680 shares at an effective combined price of $0.51 per share. Gross proceeds are expected to be approximately $8.5 million, with closing expected on or about October 19, 2026. Net proceeds are intended to fund research and development activities and for working capital and general corporate purposes, with proceeds expected t...
Key takeaways
Offering size: 16,666,680 shares (or pre-funded warrants) plus common warrants to purchase an additional 16,666,680 shares at an effective combined price of $0.51 per share
Gross proceeds: approximately $8.5 million before placement fees and expenses
Common warrants: exercise price $0.60 per share, exercisable six months following issuance, expiring April 19, 2032 (5.5-year term)
Pre-funded warrants: exercise price $0.01 per share, exercisable immediately upon issuance
Use of proceeds: research and development activities, working capital, and general corporate purposes; expected to fund operations through initial CLL data in December 2026
Closing expected on or about October 19, 2026, subject to customary closing conditions
Placement agents: A.G.P./Alliance Global Partners (lead) and Laidlaw & Company (UK) Ltd. (co-placement agent); aggregate cash fee of 6.5% of gross proceeds, plus up to $85,000 in legal expense reimbursement and up to $10,000 in non-accountable expenses
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow CRIS in real time
Get material earnings, filing, IR, and earnings-call alerts by email.